[Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu

Yang Yang1, Rui Cheng, Qi Wu

  • 1Children's Hospital Affiliated to Nanjing Medical University, Nanjing 210008, China. chengrui351@163.com.

Insights

Early caffeine use in preterm infants (gestational age ≤31 weeks) reduced treatment duration, oxygen needs, and hospital stay without significant adverse effects. This approach is safe and effective for neonates.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Pediatric Critical Care

Background:

  • Caffeine is commonly used to treat apnea in preterm infants.
  • Optimal timing for initiating caffeine therapy remains under investigation.

Purpose of the Study:

  • To evaluate the efficacy and safety of early versus late caffeine administration in preterm infants (≤31 weeks gestational age).

Main Methods:

  • Retrospective analysis of 640 preterm infants in China.
  • Comparison of clinical data between early (≤72 hours) and late (>72 hours) caffeine use groups.

Main Results:

  • Early caffeine use was associated with shorter treatment duration, reduced apnea incidence, shorter oxygen supply time, and decreased hospital stay.
  • No significant differences in major neonatal morbidities (e.g., intracranial hemorrhage, necrotizing enterocolitis) or mortality were observed.
  • Bronchopulmonary dysplasia incidence and home oxygen therapy rates differed between groups.

Conclusions:

  • Early caffeine administration in preterm infants (≤31 weeks) is effective in shortening treatment and hospital stay with minimal adverse effects.
  • This strategy offers potential benefits for neonatal intensive care unit management.
Abstract

Related Concept Videos